Although we observed that circulating adiponectin levels in ELGANs with hyperglycemia were significantly lower than in infants who were normoglycemic, the low number of patients in our study impedes a clear interpretation of the differences in adiponectin levels between the two cohorts at term-equivalent age. The gene discussed is ADIPOQ; the disease is Hyperglycemia.